Ronald Hoffman

Ronald Hoffman

UNVERIFIED PROFILE

Are you Ronald Hoffman?   Register this Author

Register author
Ronald Hoffman

Ronald Hoffman

Publications by authors named "Ronald Hoffman"

Are you Ronald Hoffman?   Register this Author

100Publications

2408Reads

11Profile Views

Outcomes of splanchnic vein thrombosis in patients with myeloproliferative neoplasms in a single center experience.

Eur J Haematol 2019 Oct 6. Epub 2019 Oct 6.

Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, New York.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/ejh.13335DOI Listing
October 2019

Oral idasanutlin in patients with polycythemia vera.

Blood 2019 Aug 5;134(6):525-533. Epub 2019 Jun 5.

Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, NY.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1182/blood.2018893545DOI Listing
August 2019

Ex vivo HSC expansion challenges the paradigm of unidirectional human hematopoiesis.

Ann N Y Acad Sci 2019 Jun 14. Epub 2019 Jun 14.

Division of Hematology/Oncology, Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, New York.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/nyas.14133DOI Listing
June 2019

Ex Vivo Expansion of Hematopoietic Stem Cells from Human Umbilical Cord Blood-derived CD34+ Cells Using Valproic Acid.

J Vis Exp 2019 Apr 11(146). Epub 2019 Apr 11.

Division of Hematology/Oncology, Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3791/59532DOI Listing
April 2019

Mitochondrial Role in Stemness and Differentiation of Hematopoietic Stem Cells.

Stem Cells Int 2019 6;2019:4067162. Epub 2019 Feb 6.

Division of Hematology/Oncology, Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, NY 10029, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1155/2019/4067162DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6381553PMC
February 2019

Novel treatments to tackle myelofibrosis.

Expert Rev Hematol 2018 11 26;11(11):889-902. Epub 2018 Oct 26.

a Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai , Myeloproliferative Neoplasms Research Program , New York , NY , USA.

View Article

Download full-text PDF

Source
https://www.tandfonline.com/doi/full/10.1080/17474086.2018.1
Publisher Site
http://dx.doi.org/10.1080/17474086.2018.1536538DOI Listing
November 2018

Genomic characterization of spleens in patients with myelofibrosis.

Haematologica 2018 10 10;103(10):e446-e449. Epub 2018 May 10.

Myeloproliferative Neoplasms Research Program, Department of Hematology and Oncology, Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, Rockefeller University, New York, NY, USA

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3324/haematol.2018.193763DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6165826PMC
October 2018

Dysregulated iron metabolism in polycythemia vera: etiology and consequences.

Leukemia 2018 10 24;32(10):2105-2116. Epub 2018 Jul 24.

Division of Hematology Oncology, Icahn School of Medicine at Mount Sinai, New York, NY, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/s41375-018-0207-9DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6170398PMC
October 2018

Imetelstat, a telomerase inhibitor, is capable of depleting myelofibrosis stem and progenitor cells.

Blood Adv 2018 09;2(18):2378-2388

Division of Hematology/Medical Oncology/Pathology, Department of Medicine, The Tisch Cancer Institute, Myeloproliferative Neoplasms Research Consortium, Icahn School of Medicine at Mount Sinai, New York, NY.

View Article

Download full-text PDF

Source
http://www.bloodadvances.org/lookup/doi/10.1182/bloodadvance
Publisher Site
http://dx.doi.org/10.1182/bloodadvances.2018022012DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6156882PMC
September 2018

Outcomes and predictors of survival in blast phase myeloproliferative neoplasms.

Leuk Res 2018 07 21;70:49-55. Epub 2018 May 21.

Massachusetts General Hospital, Harvard Medical School, Boston, MA, United States. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.leukres.2018.05.004DOI Listing
July 2018

Whirling Platelets Away for Transfusion.

Cell 2018 07;174(3):503-504

Department of Biomedical and Neuromotorial Sciences, Alma Mater University, Bologna, Italy. Electronic address:

View Article

Download full-text PDF

Source
https://linkinghub.elsevier.com/retrieve/pii/S00928674183091
Publisher Site
http://dx.doi.org/10.1016/j.cell.2018.07.018DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6487281PMC
July 2018

Current approaches to challenging scenarios in myeloproliferative neoplasms.

Expert Rev Anticancer Ther 2018 06 29;18(6):567-578. Epub 2018 Mar 29.

a Icahn School of Medicine at Mount Sinai , Tisch Cancer Institute , New York , NY , USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1080/14737140.2018.1457441DOI Listing
June 2018

The characteristics of vessel lining cells in normal spleens and their role in the pathobiology of myelofibrosis.

Blood Adv 2018 05;2(10):1130-1145

Division of Hematology/Medical Oncology, Department of Medicine, Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, NY; and.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1182/bloodadvances.2017015073DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5965045PMC
May 2018

Survey and evaluation of mutations in the human KLF1 transcription unit.

Sci Rep 2018 04 26;8(1):6587. Epub 2018 Apr 26.

Department of Cell, Developmental, and Regenerative Biology, Mount Sinai School of Medicine, New York, NY, 10029, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/s41598-018-24962-3DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5920080PMC
April 2018

Don't judge a JAK2 inhibitor by spleen response alone.

Lancet Haematol 2018 02 20;5(2):e56-e57. Epub 2017 Dec 20.

Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York City, NY 10029, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/S2352-3026(17)30236-3DOI Listing
February 2018

Preferences of Patients With Myeloproliferative Neoplasms for Accepting Anxiety or Depression Treatment.

Psychosomatics 2017 Jan - Feb;58(1):56-63. Epub 2016 Aug 17.

Division of Hematology/Oncology, Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai Hospital, New York, NY.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.psym.2016.08.006DOI Listing
November 2017

Psychological Manifestations of Early Childhood Adversity in the Context of Chronic Hematologic Malignancy.

Psychosomatics 2017 Jan - Feb;58(1):46-55. Epub 2016 Oct 5.

Division of Hematology/Oncology, Department of Medicine, Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai Hospital.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.psym.2016.10.002DOI Listing
November 2017

A phase II study of panobinostat in patients with primary myelofibrosis (PMF) and post-polycythemia vera/essential thrombocythemia myelofibrosis (post-PV/ET MF).

Leuk Res 2017 02 30;53:13-19. Epub 2016 Nov 30.

Tisch Cancer Institute, Division of Hemato and Oncologylogy, Icahn School of Medicine at Mount Sinai, New York, NY, United States.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.leukres.2016.11.015DOI Listing
February 2017

Alox5 Blockade Eradicates JAK2V617F-Induced Polycythemia Vera in Mice.

Cancer Res 2017 01 26;77(1):164-174. Epub 2016 Oct 26.

Division of Hematology/Oncology, Department of Medicine, University of Massachusetts Medical School, Worcester, Massachusetts.

View Article

Download full-text PDF

Source
http://cancerres.aacrjournals.org/lookup/doi/10.1158/0008-54
Publisher Site
http://dx.doi.org/10.1158/0008-5472.CAN-15-2933DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5217717PMC
January 2017

Preclinical rationale for TGF-β inhibition as a therapeutic target for the treatment of myelofibrosis.

Exp Hematol 2016 Dec 31;44(12):1138-1155.e4. Epub 2016 Aug 31.

Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, NY, USA; Department of Biomedical and Neuromotorial Sciences, Alma Mater University, Bologna, Italy. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.exphem.2016.08.007DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5778911PMC
December 2016

Outcome of Allogeneic Hematopoietic Stem Cell Transplantation for Patients with Chronic and Advanced Phase Myelofibrosis.

Biol Blood Marrow Transplant 2016 12 3;22(12):2180-2186. Epub 2016 Sep 3.

Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, New York. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.bbmt.2016.08.029DOI Listing
December 2016

Psychological Symptoms Among Patients With BCR-ABL-Negative Myeloproliferative Neoplasms.

J Natl Compr Canc Netw 2016 12;14(12):1563-1570

From Division of Network Services, Department of Medicine, Memorial Sloan Kettering Cancer Center, West Harrison; Division of Hematology/Oncology, Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai Hospital, New York; and Department of Psychiatry and Behavioral Sciences, Memorial Sloan Kettering Cancer Center, New York, New York.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.6004/jnccn.2016.0168DOI Listing
December 2016

Continued Role of Splenectomy in the Management of Patients With Myelofibrosis.

Clin Lymphoma Myeloma Leuk 2016 09 8;16(9):e133-e137. Epub 2016 Jun 8.

Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, NY. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.clml.2016.06.007DOI Listing
September 2016

Outcome Disparities in Caucasian and Non-Caucasian Patients With Myeloproliferative Neoplasms.

Clin Lymphoma Myeloma Leuk 2016 Jun 8;16(6):350-7. Epub 2016 Mar 8.

Division of Hematology/Oncology, University of Illinois Hospital and Health Sciences System, Chicago, IL.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.clml.2016.02.036DOI Listing
June 2016

A thrombopoietin receptor antagonist is capable of depleting myelofibrosis hematopoietic stem and progenitor cells.

Blood 2016 06 25;127(26):3398-409. Epub 2016 Apr 25.

Division of Hematology/Oncology, The Tisch Cancer Institute, Department of Medicine, Myeloproliferative Disorders Research Consortium, Icahn School of Medicine at Mount Sinai, New York, NY;

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1182/blood-2015-10-674465DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4929928PMC
June 2016

Polycythemia Vera: An Appraisal of the Biology and Management 10 Years After the Discovery of JAK2 V617F.

J Clin Oncol 2015 Nov 31;33(33):3953-60. Epub 2015 Aug 31.

Brady L. Stein, Northwestern Feinberg University School of Medicine, Chicago, IL; Stephen T. Oh and Camille Abboud, Washington University School of Medicine, St Louis, MO; Dmitriy Berenzon, Wake Forest University School of Medicine, Winston Salem, NC; Gabriela S. Hobbs, Massachusetts General Hospital, Boston, MA; Marina Kremyanskaya, John Mascarenhas, and Ronald Hoffman, Mount Sinai School of Medicine; Raajit K. Rampal, Memorial Sloan Kettering Cancer Center; Mark L. Heaney, Columbia University Medical Center; Ellen K. Ritchie, Cornell University School of Medicine, New York, NY; Kenneth Adler, Regional Cancer Care Associates, Morristown, NJ; Elias J. Jabbour, MD Anderson Cancer Center; Lawrence Rice, Cornell Houston Methodist Hospital, Houston, TX; Rami S. Komrokji, Moffitt Cancer Center, Tampa, FL; and Alison R. Moliterno, Johns Hopkins University School of Medicine, Baltimore, MD.

View Article

Download full-text PDF

Source
http://jco.ascopubs.org/content/early/2015/08/31/JCO.2015.61
Web Search
http://jco.ascopubs.org/cgi/doi/10.1200/JCO.2015.61.6474
Publisher Site
http://dx.doi.org/10.1200/JCO.2015.61.6474DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4979103PMC
November 2015

Lipocalin produced by myelofibrosis cells affects the fate of both hematopoietic and marrow microenvironmental cells.

Blood 2015 Aug 28;126(8):972-82. Epub 2015 May 28.

Division of Hematology/Oncology, Department of Medicine and The Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, NY;

View Article

Download full-text PDF

Source
http://www.bloodjournal.org/cgi/doi/10.1182/blood-2014-12-61
Publisher Site
http://dx.doi.org/10.1182/blood-2014-12-618595DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4543230PMC
August 2015

In Support of a Patient-Driven Initiative and Petition to Lower the High Price of Cancer Drugs.

Authors:
Ayalew Tefferi Hagop Kantarjian S Vincent Rajkumar Lawrence H Baker Jan L Abkowitz John W Adamson Ranjana Hira Advani James Allison Karen H Antman Robert C Bast John M Bennett Edward J Benz Nancy Berliner Joseph Bertino Ravi Bhatia Smita Bhatia Deepa Bhojwani Charles D Blanke Clara D Bloomfield Linda Bosserman Hal E Broxmeyer John C Byrd Fernando Cabanillas George Peter Canellos Bruce A Chabner Asher Chanan-Khan Bruce Cheson Bayard Clarkson Susan L Cohn Gerardo Colon-Otero Jorge Cortes Steven Coutre Massimo Cristofanilli Walter J Curran George Q Daley Daniel J DeAngelo H Joachim Deeg Lawrence H Einhorn Harry P Erba Francisco J Esteva Elihu Estey Isaiah J Fidler James Foran Stephen Forman Emil Freireich Charles Fuchs James N George Morie A Gertz Sergio Giralt Harvey Golomb Peter Greenberg Jordan Gutterman Robert I Handin Samuel Hellman Paulo Marcelo Hoff Ronald Hoffman Waun Ki Hong Mary Horowitz Gabriel N Hortobagyi Clifford Hudis Jean Pierre Issa Bruce Evan Johnson Philip W Kantoff Kenneth Kaushansky David Khayat Fadlo R Khuri Thomas J Kipps Margaret Kripke Robert A Kyle Richard A Larson Theodore S Lawrence Ross Levine Michael P Link Scott M Lippman Sagar Lonial Gary H Lyman Maurie Markman John Mendelsohn Neal J Meropol Yoav Messinger Therese M Mulvey Susan O'Brien Roman Perez-Soler Raphael Pollock Josef Prchal Oliver Press Jerald Radich Kanti Rai Saul A Rosenberg Jacob M Rowe Hope Rugo Carolyn D Runowicz Brenda M Sandmaier Alan Saven Andrew I Schafer Charles Schiffer Mikkael A Sekeres Richard T Silver Lillian L Siu David P Steensma F Marc Stewart Wendy Stock Richard Stone Rainer Storb Louise C Strong Martin S Tallman Michael Thompson Naoto T Ueno Richard A Van Etten Julie M Vose Peter H Wiernik Eric P Winer Anas Younes Andrew D Zelenetz Charles A LeMaistre

Mayo Clin Proc 2015 Aug 23;90(8):996-1000. Epub 2015 Jul 23.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.mayocp.2015.06.001DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5365030PMC
August 2015

Role of epigenetic reprogramming in hematopoietic stem cell function.

Curr Opin Hematol 2015 Jul;22(4):279-85

The Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, New York, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/MOH.0000000000000143DOI Listing
July 2015

Anagrelide hydrochloride and ruxolitinib for treatment of polycythemia vera.

Expert Opin Pharmacother 2015 Jun 14;16(8):1185-94. Epub 2015 Apr 14.

Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai , 1 Gustave L Levy Place Box 1079, New York, NY 10029 , USA

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1517/14656566.2015.1036029DOI Listing
June 2015

C-X-C motif chemokine 12 influences the development of extramedullary hematopoiesis in the spleens of myelofibrosis patients.

Exp Hematol 2015 Feb 8;43(2):100-9.e1. Epub 2014 Nov 8.

Division of Hematology/Oncology, The Tisch Cancer Institute, Department of Medicine, Myeloproliferative Disorders Research Consortium, The Icahn School of Medicine at Mount Sinai, New York, NY, USA. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.exphem.2014.10.013DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4324010PMC
February 2015

JAK2 inhibitors do not affect stem cells present in the spleens of patients with myelofibrosis.

Blood 2014 Nov 5;124(19):2987-95. Epub 2014 Sep 5.

Division of Hematology/Oncology/Pathology, The Tisch Cancer Institute, Department of Medicine, Myeloproliferative Disorders Research Consortium, Icahn School of Medicine at Mount Sinai, New York, NY; and.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1182/blood-2014-02-558015DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4224194PMC
November 2014

Development of extramedullary sites of leukaemia during ruxolitinib therapy for myelofibrosis.

Br J Haematol 2014 Oct 26;167(1):144-6. Epub 2014 May 26.

Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, NY, USA.

View Article

Download full-text PDF

Source
http://doi.wiley.com/10.1111/bjh.12948
Publisher Site
http://dx.doi.org/10.1111/bjh.12948DOI Listing
October 2014

An association of myeloproliferative neoplasms and obliterative portal venopathy.

Dig Dis Sci 2014 Jul 29;59(7):1638-41. Epub 2014 Jan 29.

Division of Hematology/Oncology, Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, One Gustave L Levy Place, Box 1079, New York, NY, 10029, USA.

View Article

Download full-text PDF

Source
http://link.springer.com/10.1007/s10620-013-3018-x
Publisher Site
http://dx.doi.org/10.1007/s10620-013-3018-xDOI Listing
July 2014

The orally bioavailable MDM2 antagonist RG7112 and pegylated interferon α 2a target JAK2V617F-positive progenitor and stem cells.

Blood 2014 Jul 28;124(5):771-9. Epub 2014 May 28.

Division of Hematology/Oncology, the Tisch Cancer Institute and Department of Medicine, Icahn School of Medicine at Mount Sinai, New York, NY.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1182/blood-2013-11-536854DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4467881PMC
July 2014

Optimal therapy for polycythemia vera and essential thrombocythemia can only be determined by the completion of randomized clinical trials.

Haematologica 2014 Jun;99(6):945-9

Hematology and Oncology Section, Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, NY.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3324/haematol.2014.106013DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4040888PMC
June 2014

Anti-transforming growth factor-β therapy in patients with myelofibrosis.

Leuk Lymphoma 2014 Feb 24;55(2):450-2. Epub 2013 Jun 24.

The Tisch Cancer Institute.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3109/10428194.2013.805329DOI Listing
February 2014

Coexistence of myeloproliferative neoplasm and plasma-cell dyscrasia.

Clin Lymphoma Myeloma Leuk 2014 Feb 30;14(1):31-6. Epub 2013 Sep 30.

Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, NY. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.clml.2013.09.015DOI Listing
February 2014

Activation of p53 by the MDM2 inhibitor RG7112 impairs thrombopoiesis.

Exp Hematol 2014 Feb 3;42(2):137-45.e5. Epub 2013 Dec 3.

Division of Hematology and Medical Oncology, Department of Medicine and The Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, NY, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.exphem.2013.11.012DOI Listing
February 2014

Clarifying the use of ruxolitinib in patients with myelofibrosis.

Oncology (Williston Park) 2013 Jul;27(7):706-14

Tisch Cancer Institute, Mount Sinai School of Medicine, New York, New York, USA.

View Article

Download full-text PDF

Source
July 2013

Kinetic modeling of dissolution and crystallization of slurries with attenuated total reflectance UV-visible absorbance and near-infrared reflectance measurements.

Anal Chem 2013 Jun 16;85(11):5367-75. Epub 2013 May 16.

Department of Chemistry, East Carolina University, Greenville, NC, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1021/ac302766mDOI Listing
June 2013

A comprehensive review and analysis of the effect of ruxolitinib therapy on the survival of patients with myelofibrosis.

Blood 2013 Jun 9;121(24):4832-7. Epub 2013 Apr 9.

Tisch Cancer Institute, Mount Sinai School of Medicine, 1 Gustave L Levy Place, New York, NY 10029, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1182/blood-2013-02-482232DOI Listing
June 2013

A phase I study of panobinostat (LBH589) in patients with primary myelofibrosis (PMF) and post-polycythaemia vera/essential thrombocythaemia myelofibrosis (post-PV/ET MF).

Br J Haematol 2013 Apr 21;161(1):68-75. Epub 2013 Jan 21.

Division of Hematology, Tisch Cancer Institute, Mount Sinai School of Medicine, New York, NY 10029, USA.

View Article

Download full-text PDF

Source
http://doi.wiley.com/10.1111/bjh.12220
Publisher Site
http://dx.doi.org/10.1111/bjh.12220DOI Listing
April 2013

Stromal cell-mediated inhibition of erythropoiesis can be attenuated by Sotatercept (ACE-011), an activin receptor type II ligand trap.

Exp Hematol 2013 Feb 20;41(2):155-166.e17. Epub 2012 Dec 20.

Division of Hematology and Medical Oncology, The Tisch Cancer Institute, Mount Sinai School of Medicine, New York, NY 10029, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.exphem.2012.12.002DOI Listing
February 2013

Wheezing and asthma are independent risk factors for increased sickle cell disease morbidity.

Br J Haematol 2012 Nov 12;159(4):472-9. Epub 2012 Sep 12.

Department of Emergency Medicine, Mount Sinai School of Medicine, New York, NY 10029, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/bjh.12049DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3758903PMC
November 2012

Spleens of myelofibrosis patients contain malignant hematopoietic stem cells.

J Clin Invest 2012 Nov;122(11):3888-99

Division of Hematology/Oncology, Pathology and Surgery, Tisch Cancer Institute, Myeloproliferative Disorders Research Consortium, Mount Sinai School of Medicine, New York, New York 10029, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1172/JCI64397DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3484080PMC
November 2012

Combination treatment in vitro with Nutlin, a small-molecule antagonist of MDM2, and pegylated interferon-α 2a specifically targets JAK2V617F-positive polycythemia vera cells.

Blood 2012 Oct 7;120(15):3098-105. Epub 2012 Aug 7.

Division of Hematology/Oncology, Tisch Cancer Institute and Department of Medicine, Mount Sinai School of Medicine, New York, NY 10029, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1182/blood-2012-02-410712DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3471518PMC
October 2012

Allogeneic hematopoietic cell transplantation for myelofibrosis in the era of JAK inhibitors.

Blood 2012 Aug 14;120(7):1367-79. Epub 2012 Jun 14.

Princess Margaret Hospital, University of Toronto, Ontario, Canada.

View Article

Download full-text PDF

Source
http://www.bloodjournal.org/cgi/doi/10.1182/blood-2012-05-39
Publisher Site
http://dx.doi.org/10.1182/blood-2012-05-399048DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5800543PMC
August 2012

Panobinostat (LBH589)-induced acetylation of tubulin impairs megakaryocyte maturation and platelet formation.

Exp Hematol 2012 Jul 27;40(7):564-74. Epub 2012 Feb 27.

Division of Hematology and Medical Oncology, Department of Medicine and The Tisch Cancer Institute, Mount Sinai School of Medicine, New York, NY 10029, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.exphem.2012.02.004DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3381910PMC
July 2012

Ruxolitinib: the first FDA approved therapy for the treatment of myelofibrosis.

Clin Cancer Res 2012 Jun 2;18(11):3008-14. Epub 2012 Apr 2.

Division of Hematology/Oncology, Tisch Cancer Institute, Mount Sinai School of Medicine, New York, NY 10029, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/1078-0432.CCR-11-3145DOI Listing
June 2012

Why does my patient have erythrocytosis?

Hematol Oncol Clin North Am 2012 Apr;26(2):267-83, vii-viii

Department of Hematology/Oncology, Tisch Cancer Institute, Mount Sinai School of Medicine, One Gustave L. Levy Place, Box 1079, New York, NY 10029, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.hoc.2012.02.011DOI Listing
April 2012

IgG4-related disease presenting as recurrent mastoiditis.

Laryngoscope 2012 Mar 17;122(3):681-4. Epub 2012 Jan 17.

National Institute of Arthritis and Musculoskeletal and Skin Disease, National Human Genome Research Institute, National Institutes of Health, Bethesda, Maryland 20892-1616, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/lary.22486DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3547986PMC
March 2012

Laser-capture microdissection and analysis of liver endothelial cells from patients with Budd-Chiari syndrome.

Methods Mol Biol 2011 ;755:405-15

Research Institute for Experimental Medicine (DETAE), Istanbul University, Istanbul, Turkey.

View Article

Download full-text PDF

Source
http://link.springer.com/10.1007/978-1-61779-163-5_34
Publisher Site
http://dx.doi.org/10.1007/978-1-61779-163-5_34DOI Listing
November 2011

Clinical and laboratory features of myelofibrosis and limitations of current therapies.

Clin Adv Hematol Oncol 2011 Sep;9(9 Suppl 22):1-16

Department of Internal Medicine, Rush University Medical Center/Rush University, Chicago, Illinois, USA.

View Article

Download full-text PDF

Source
September 2011

Unusual electroacoustic device failure and electroacoustic reimplantation with hearing preservation.

Otol Neurotol 2011 Aug;32(6):948-50

Department of Otolaryngology, Head and Neck Surgery, Ear Institute, New York Eye and Ear Infirmary, New York, New York, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/MAO.0b013e31821ac88aDOI Listing
August 2011

Myeloproliferative neoplasms: new translational therapies.

Mt Sinai J Med 2010 Nov-Dec;77(6):667-83

Mount Sinai School of Medicine, New York, NY, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/msj.20225DOI Listing
June 2011

The renaissance of interferon therapy for the treatment of myeloid malignancies.

Blood 2011 May 9;117(18):4706-15. Epub 2011 Mar 9.

Hôpital Saint-Louis, Assistance Publique-Hôpitaux de Paris, Paris, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1182/blood-2010-08-258772DOI Listing
May 2011

Chromatin-modifying agents promote the ex vivo production of functional human erythroid progenitor cells.

Blood 2011 Apr 25;117(17):4632-41. Epub 2011 Feb 25.

Division of Hematology/Medical Oncology, Department of Medicine, Tisch Cancer Institute, Mount Sinai School of Medicine, New York, NY, USA.

View Article

Download full-text PDF

Source
http://www.bloodjournal.org/cgi/doi/10.1182/blood-2010-10-31
Publisher Site
http://dx.doi.org/10.1182/blood-2010-10-314567DOI Listing
April 2011

Down-regulation of stathmin expression is required for megakaryocyte maturation and platelet production.

Blood 2011 Apr 1;117(17):4580-9. Epub 2011 Mar 1.

Division of Hematology and Medical Oncology, Department of Medicine, and Tisch Cancer Institute, Mount Sinai School of Medicine, New York, NY, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1182/blood-2010-09-305540DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3099574PMC
April 2011

Development of t(8;21) and RUNX1-RUNX1T1 in the Philadelphia-positive clone of a patient with chronic myelogenous leukemia: additional evidence for multiple steps involved in disease progression.

Cancer Genet 2011 Mar;204(3):165-70

Tumor Cytogenetics Laboratory, Department of Pathology, The Myeloproliferative Program, Tisch Cancer Center, The Mount Sinai School of Medicine, New York, New York, USA.

View Article

Download full-text PDF

Source
http://linkinghub.elsevier.com/retrieve/pii/S016546081000490
Publisher Site
http://dx.doi.org/10.1016/j.cancergencyto.2010.09.001DOI Listing
March 2011

Frequency of heterozygous TET2 deletions in myeloproliferative neoplasms.

Cancer Manag Res 2010 Sep 17;2:219-23. Epub 2010 Sep 17.

The Myeloproliferative Disorders Program, Tisch Cancer Institute, Department of Medicine and.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.2147/CMR.S12829DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3004566PMC
September 2010